Let’s talk about pain
Our nation is severely lacking in its approach to chronic pain. Nobody should ever resign themselves to forever experiencing pain and end their life or […]
Chronic pain
Breaking into the global pharmaceutical market
In 2022, pharma is truly a global industry, and innovation can come from anywhere. But for small life sciences outside of the USA and Europe, […]
SMi’s 22nd Annual Pain Therapeutics Conference
http://www.pain-therapeutics.co.uk/pharmaphorum Sponsored by: CHDR Conference Chairman: Richard Malamut, Chief Medical Officer, Collegium Pharmaceutical, Inc Novel Compounds and Treatments for Pain: Opioids and the Alternatives SMi’s […]
Revised CDC guidelines on opioids are a step in the right direction, but much work remains
More restrictive opioid prescribing guidelines were put in place in a rightful effort to stop a devastating crisis. But this sudden and dramatic change negatively […]
Virtual reality therapy: The future of chronic pain management?
Could virtual reality tools be effective in helping patients ‘unlearn’ their chronic pain? pharmaphorum speaks to Professor Christopher Eccleston from the University of Bath’s Centre […]
MedTech Wrap Up
Neuros Medical Receives FDA Breakthrough Device Designation for its Novel Altius® High-Frequency Nerve Block System On June 29, 2021, the US Food and Drug Administration […]
Startup gets FDA-clearance for device to treat chronic pain
Neuralace Medical, a San Diego-based startup, recently got FDA clearance for a non-invasive device to treat chronic pain. It works by stimulating nerve fibers that […]
Trial finds Orion digital therapeutic helps chronic pain sufferers
A digital therapeutic aimed at people with chronic lower back pain based on virtual reality (VR) has shown encouraging results in a clinical trial, helping […]
AppliedVR raises $29M as it seeks FDA clearance of VR system for pain treatment
Earlier this year, AppliedVR shared results of a pivotal study that it plans to submit to the FDA. It received a breakthrough device designation last […]
Lilly Signs a License Agreement with Asahi Kasei Pharma for AK1780 to Treat Chronic Pain
Shots: Asahi Kasei to receive an $20M up front, ~$210M as development & regulatory milestones and will be eligible for ~$180M milestones along with royalties […]
AppliedVR gets breakthrough device designation for VR to treat pain
The Los Angeles-based startup received a breakthrough device designation from the FDA for using VR to manage chronic pain. It recently published the results of […]
Pilot study backs Kaia Health app for back pain relief
An app developed by Kaia Health to help people suffering from back pain who may not want to take painkillers has shown its worth again […]
Kaia app for lower back pain shows its worth in large-scale trial
An app combining physical therapy, relaxation exercises and medical education developed by Kaia Health has been shown to improve physical and mental symptoms in people […]
